Skip to main content

SAVE THE DATE FOR OUR CLL IRELAND PATIENT & CARER INFORMATION DAY ON OCTOBER 5TH!

 

Welcome to CLL Ireland

A Patient Advocacy Group

Cll Ireland Is a Patient-Led Advocacy Group.

Our goal, is to ensure that anyone affected by Chronic Lymphocytic Leukaemia (CLL) can gain access to the information, advice and support they need when they need it!

Important Information

Living with CLL

Learn more about CLL

Treatment

What type of treatments are available?

Support

Getting support to make the difference

Community & Research

Learn more about what's happening in the CLL Community

FAQ’s

We try to answer your most common questions

Latest News

Ireland needs similar action👇
Australia’s Blood Cancer Taskforce has today released five new “optimal care pathways” (OCPs) aimed at improving treatment consistency and reducing avoidable deaths from blood cancer.
@DonnellyStephen
https://www.petermac.org/about-us/news-and-events/news/details/new-guides-to-reduce-avoidable-deaths-from-blood-cancer

Load More
Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
6 days ago
CLL Ireland

CLL Ireland patient and care partner information day takes place on October 5th.

Learn how to live well with CLL.
A great line up of speakers.

Registration link is now open.

www.eventbrite.ie/e/cll-ireland-patient-care-partner-information-day-tickets-934542611107?aff=odd...
... See MoreSee Less

CLL Ireland patient and care partner information day takes place on October 5th.
Learn how to live well with CLL.
A great line up of speakers.
Registration link is now open.
https://www.eventbrite.ie/e/cll-ireland-patient-care-partner-information-day-tickets-934542611107?aff=oddtdtcreator
3 weeks ago
CLL Ireland

More on the new agent for treating CLL from CLL Society's Dr Brian Koffman who interviewed Dr. Alexey Danilov from City of Hope National Medical Center who presented the study design at the American Society for Hematology (ASH) Meeting 2023.

Background:

NX-5948 is a new type of drug known as a BTK degrader.

Hear the interview from ASH23 in the link.

The update from EHA 24 on this drug are very promising which we reported last week.
See attached slides.

cllsociety.org/2024/06/initial-study-and-findings-for-btk-degrader-to-treat-cll/
... See MoreSee Less

More on the new agent for treating CLL from CLL Societys Dr Brian Koffman who interviewed Dr. Alexey Danilov from City of Hope National Medical Center who presented the study design at the American Society for Hematology (ASH) Meeting 2023.
Background:
NX-5948 is a new type of drug known as a BTK degrader.
Hear the interview from ASH23 in the link.
The update from EHA 24 on this drug are very promising which we reported last week.
See attached slides.
https://cllsociety.org/2024/06/initial-study-and-findings-for-btk-degrader-to-treat-cll/Image attachmentImage attachment+3Image attachment
Load more

Ireland needs similar action👇
Australia’s Blood Cancer Taskforce has today released five new “optimal care pathways” (OCPs) aimed at improving treatment consistency and reducing avoidable deaths from blood cancer.
@DonnellyStephen
https://www.petermac.org/about-us/news-and-events/news/details/new-guides-to-reduce-avoidable-deaths-from-blood-cancer

Load More

Looking for more information about CLL?

We’ve produced a handy booklet explaining all about CLL. We cover such topics as:

  • What is CLL?
  • Signs & Symptoms of CLL
  • Staging
  • Treating CLL
  • Complications of CLL
  • Living with CLL
  • Talking about CLL

and much more! Click on the button below to open the file – it’s a great resource and we’re delighted to share it with you!

Click Here For CLL Booklet!

Get in touch with

CLL Ireland today

Click Here

Information about CLL

We’ve put together a set of resources to help you on your journey with CLL. Click to find out more!

Donate Now

Support our services and help us to continue our advocacy work. Your donation will help make a difference.

Skip to content